Lumida
/GERN
⌘K
Geron Corp

Geron Corp

GERN
$1.35USD-1.46%-0.02 today

MARKET CAP

867.3M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2

AI Summary

Stalk
Sell NowMedium

GERN has decisively broken key support and entered a Stage 3 distribution phase, with price now below declining EMAs and showing no sign of exhaustion despite extreme oversold readings. The active Support Failure pattern underscores supply dominance and further downside potential. Medium‐term bias remains bearish, and short‐term momentum favors selling now to capture the breakdown continuation before any relief rally into the broken EMA zone.

  • Q2 net revenue of $57.5M drove 17% YoY and 11% QoQ growth
  • Raised full-year 2026 guidance to $220–240M on continued demand
  • Low earnings yield and weak book‐to‐price metrics suggest overvaluation
Full analysis →
Insider Trades8 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 18, 2026SellGERNMichelle RobertsonEVP, CHIEF FINANCIAL OFFICER9,855$1.94$867.3M-32.84%+29.81%$19.1K-0.56%Stalk
Feb 27, 2025BuyGERNJohn A ScarlettChairman, President and CEO12,500$1.76$867.3M-32.84%+29.81%$22.1KStalk
Feb 27, 2025BuyGERNScott Alan SamuelsEVP, Chief Legal Officer15,000$1.61$867.3M-32.84%+29.81%$24.1K+128.40%Stalk
Feb 27, 2025BuyGERNJames ZieglerEVP, Chief Commercial Officer100,000$1.60$867.3M-32.84%+29.81%$160.0KStalk
Jul 8, 2024SellGERNAndrew J GrethleinEVP, Chief Operating Officer1,348,696$3.14$867.3M-32.84%+29.81%$4.2M+0.00%Stalk
Jun 10, 2024SellGERNFaye FellerEVP, Chief Medical Officer575,800$2.91$867.3M-32.84%+29.81%$1.7M+0.00%Stalk
Jun 10, 2024SellGERNAnil KapurEVP, Corp Strategy & CCO843,750$2.85$867.3M-32.84%+29.81%$2.4M+0.00%Stalk
Jun 4, 2024SellGERNJohn A ScarlettChairman, President and CEO1,200,000$3.27$867.3M-32.84%+29.81%$3.9M+0.00%10b5-1Stalk